Micro Systemation: Update of legal dispute between Micro Systemation and Cellebrite
Without any advance notice, Cellebrite filed suit in U.S. federal court on the afternoon of Friday, August 16, 2013 with a demand that MSAB respond to Cellebrite’s allegations in less than one week. In short order, MSAB thoroughly reviewed Cellebrite’s proffered evidence and determined that Cellebrite’s claims are unfounded. MSAB also determined that Cellebrite’s allegations, even if believed, actually concern less than 1% of the XRY software functionality and will not impact MSAB’s ongoing and future support of its customers.
MSAB believes Cellebrite’s suit was brought in a bad faith attempt to injure MSAB and gain a competitive advantage. MSAB is now preparing a motion to dismiss some or all of Cellebrite’s claims, anticipates prosecuting counterclaims against Cellebrite, and looks forward to prevailing in this suit.
Micro Systemation AB is required under the Financial Instruments Trading Act to make the information in this press release public. The information was submitted for publication at 01:00 pm CEST on September 5, 2013.
Micro Systemation is a world leader in mobile forensics technology in order to extract and analyze data from confiscated mobile devices, mainly from mobile phones. The Micro Systemation group has sales offices and sales channels in Europe, USA, Latin America, China and Russia, and covers with a number of distributors, most of the world. The Micro Systemation product portfolio has become a de facto standard in its field and is used for obtaining evidence in over 50 countries. The products are accompanied by a wide program of training that allow the user to become certified in a forensic methodology. Customers are primarily criminal investigative authorities such as the police, military and customs. Micro Systemation AB is listed on NASDAQ OMX Stockholm under the ticker name: MSAB B.
CEO, Joel Bollö, +46 8 739 02 70, firstname.lastname@example.org or,
Chairman, Henrik Tjernberg, +46 8 739 02 70, email@example.com